Stock listing
AQUIS:EDX EDX Medical Group PLC Share Price
Home listing (AQUIS) of EDX Medical Group PLC
Follow EDX Medical Group PLC into a list and get an email when it puts out news.

- Ticker
- AQUIS:EDX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- AQUIS
- Currency
- GBX
What changed lately
Latest news release · Nov 17, 2026
Appointment of CEO and board changes
Latest news
Financings
Private placement of new ordinary shares of 1p each
Aug 24, 2026 · US$3.68M
Closed: £2.7M raised · £0.14 a share · Warrants at £0.03
Use of proceeds: To support the expansion of the Company's new employee health screening service.
Private placement of new ordinary shares
Feb 16, 2026 · US$4.77M
Announced: £3.5M · £0.14 a share
Use of proceeds: Accelerating the prostate cancer programme, developing and delivering diagnostic products and services
Private placement of new ordinary shares
Oct 20, 2025 · US$2.68M
Announced: £2M · £0.14 a share · Oberon Capital
Dealers: Oberon Capital (lead)
Buyers: Henrik Kraft
Use of proceeds: Accelerate commercial activity and develop new products and services, including marketing a testicular cancer testing service
Convertible loan note
Oct 20, 2025 · US$2.68M
Announced: up to £2M
Buyers: Professor Sir Chris Evans (unsecured CLN agreement for up to £2 million)
Insiders: CLN of up to £2 million issued to founder and Chief Scientific Officer Professor Sir Chris Evans, a related party transaction
Use of proceeds: Working capital or growth
Private placement of new ordinary shares
Apr 3, 2025 · US$3.89M
Update: £3M · £0.14 a share · Oberon Capital
Dealers: Oberon Capital (lead)
Buyers: Professor Sir Chris Evans (5,285,714 Subscription Shares for £740,000; now owns 36.60% of the issued share capital); Dr Mike Hudson (60,714 Subscription Shares); Martin Walton (60,714 Subscription Shares)
Insiders: Founder Sir Chris Evans subscribed for 5,285,714 shares for £740,000; CEO Dr Mike Hudson and Deputy Chair Martin Walton each subscribed for 60,714 shares
Use of proceeds: Accelerate regulatory preparation and scale up production of a new prostate cancer super test
Announced Mar 20, 2025 · Update Mar 31, 2025 · Update Apr 3, 2025
EDX Medical Group PLC on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 29 in the last 12 months · 85 in all · newest Nov 17, 2026 · oldest 2022
Where EDX Medical Group PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| AQUIS:EDX · Home listing · This page | AQUIS | United Kingdom | GBX |
| Aquis:EDXQ | Aquis | United Kingdom | GBX |
Log in to ask 6ix AI your own questions about EDX Medical Group PLC.